Scopinast

N/A

Report date: 2024/12/03 16:45:11

Base Information

Drug NameScopinast
Drug Alias NameEscopinastScopinast fumarateKA-398
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsRhinitis, Allergic, SeasonalAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDr. Willmar Schwabe
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDr. Willmar Schwabe
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic, SeasonalAsthma

Other Information

ATC CodeN/A
Related LinksN/A